Activation of Key Profibrotic Mechanisms in Transgenic Fibroblasts Expressing Kinase-deficient Type II Transforming Growth Factor-β Receptor (TβRIIΔk)
Open Access
- 1 April 2005
- journal article
- Published by Elsevier
- Vol. 280 (16) , 16053-16065
- https://doi.org/10.1074/jbc.m413134200
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Smad3 as a mediator of the fibrotic responseInternational Journal of Experimental Pathology, 2004
- Insights Into the Molecular Mechanism of Chronic Fibrosis: The Role of Connective Tissue Growth Factor in SclerodermaJournal of Investigative Dermatology, 2004
- Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblastsArthritis & Rheumatism, 2003
- Increased transcriptional activities of transforming growth factor β receptors in scleroderma fibroblastsArthritis & Rheumatism, 2002
- Dysregulation of transforming growth factor β signaling in scleroderma: Overexpression of endoglin in cutaneous scleroderma fibroblastsArthritis & Rheumatism, 2002
- Apoptosis and myofibroblasts in the pathogenesis of systemic sclerosisCurrent Rheumatology Reports, 2002
- Transforming growth factor-β and connective tissue growth factor: key cytokines in scleroderma pathogenesisCurrent Opinion in Rheumatology, 2001
- Role of apoptosis and transforming growth factor β1 in fibroblast selection and activation in systemic sclerosisArthritis & Rheumatism, 2000
- Increased Expression of TGF-β Receptors by Scleroderma Fibroblasts: Evidence for Contribution of Autocrine TGF-β Signaling to Scleroderma PhenotypeJournal of Investigative Dermatology, 1998
- Myofibroblasts from Scleroderma Skin Synthesize Elevated Levels of Collagen and Tissue Inhibitor of Metalloproteinase (TIMP-1) with Two Forms of TIMP-1Journal of Biological Chemistry, 1995